Log in to save to my catalogue

Ablation of Bscl2 /seipin in hepatocytes does not cause metabolic dysfunction in congenital generali...

Ablation of Bscl2 /seipin in hepatocytes does not cause metabolic dysfunction in congenital generali...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8d64762d0fe14cc6ae447f99eaa5483c

Ablation of Bscl2 /seipin in hepatocytes does not cause metabolic dysfunction in congenital generalised lipodystrophy

About this item

Full title

Ablation of Bscl2 /seipin in hepatocytes does not cause metabolic dysfunction in congenital generalised lipodystrophy

Publisher

England: The Company of Biologists Ltd

Journal title

Disease models & mechanisms, 2020-01, Vol.13 (1)

Language

English

Formats

Publication information

Publisher

England: The Company of Biologists Ltd

More information

Scope and Contents

Contents

Mutations affecting the
gene cause the most severe form of congenital generalised lipodystrophy (CGL). Affected individuals develop severe metabolic complications including diabetes and hepatic steatosis.
-deficient mice almost entirely reproduce the CGL phenotype. Adipose tissue-specific loss of
is also sufficient to cause early-onset gen...

Alternative Titles

Full title

Ablation of Bscl2 /seipin in hepatocytes does not cause metabolic dysfunction in congenital generalised lipodystrophy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_8d64762d0fe14cc6ae447f99eaa5483c

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8d64762d0fe14cc6ae447f99eaa5483c

Other Identifiers

ISSN

1754-8403

E-ISSN

1754-8411

DOI

10.1242/dmm.042655

How to access this item